Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
BMC Neuroscience|June 21, 2014
The prospect of molecular therapy for Angelman syndrome and other monogenic neurologic disordersBarbara J Bailus, David J SegalFrontiers in Cell and Developmental Biology|November 3, 2025
Skeleton keys and Trojan horses: a review of therapeutic delivery to the brainRachel E Stoub, Barbara J BailusBrain Research|October 3, 2015
iPSC-based drug screening for Huntington's diseaseNingzhe Zhang, Barbara J Bailus, Karen L Ring, et al.Methods in Molecular Biology (Clifton, N.J.)|March 11, 2018
Purified Protein Delivery to Activate an Epigenetically Silenced Allele in Mouse BrainBenjamin Pyles, Barbara J Bailus, Henriette O'Geen, et al.Methods in Molecular Biology (Clifton, N.J.)|August 30, 2018
In Vivo Applications of Cell-Penetrating Zinc-Finger Transcription FactorsChonghua Ren, Alexa N Adams, Benjamin Pyles, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|January 5, 2016
Protein Delivery of an Artificial Transcription Factor Restores Widespread Ube3a Expression in an Angelman Syndrome Mouse BrainBarbara J Bailus, Benjamin Pyles, Michelle M McAlister, et al.Stem Cell Reports|December 15, 2015
Genomic Analysis Reveals Disruption of Striatal Neuronal Development and Therapeutic Targets in Human Huntington's Disease Neural Stem CellsKaren L Ring, Mahru C An, Ningzhe Zhang, et al.Autophagy|May 24, 2021
Modulating FKBP5/FKBP51 and autophagy lowers HTT (huntingtin) levelsBarbara J Bailus, Stephen M Scheeler, Jesse Simons, et al.Pageof 1